Philippine Heart Center

Implicity Joins the AWS ISV Accelerate Program

Retrieved on: 
Wednesday, December 13, 2023

CAMBRIDGE, Mass., Dec. 13, 2023 /PRNewswire/ -- IMPLICITY®, a leader in remote patient monitoring and cardiac data management solutions, announced it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program, a co-sell program for AWS partners that provide software solutions that run on or integrate with AWS. The program helps AWS partners drive new business by directly connecting participating ISVs with the AWS Sales organization.

Key Points: 
  • The program helps AWS partners drive new business by directly connecting participating ISVs with the AWS Sales organization.
  • The AWS ISV Accelerate Program provides Implicity with co-sell support that enables partners to meet customer needs through collaboration with AWS field sellers globally.
  • AWS ISV Accelerate program members are held to the industry's highest standards.
  • To gain acceptance into the AWS ISV Accelerate Program, proof of customer excellence was required to validate the success users have experienced using the technology.

King Faisal Specialist Hospital and Research Centre Announces Innovative Clinical Pharmacogenomics

Retrieved on: 
Tuesday, October 24, 2023

RIYADH, Saudi Arabia, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The King Faisal Specialist Hospital and Research Centre (KFSH&RC) is proud to announce the launch of the inaugural phase of its clinical pharmacogenomics service within its Heart Center.

Key Points: 
  • RIYADH, Saudi Arabia, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The King Faisal Specialist Hospital and Research Centre (KFSH&RC) is proud to announce the launch of the inaugural phase of its clinical pharmacogenomics service within its Heart Center.
  • This innovative service is a collaborative endeavor between the Centre for Genomic Medicine, Healthcare Information Technology Affairs, and the Pharmaceutical Care Department at KFSH&RC.
  • King Faisal Specialist Hospital and Research Center is considered among the most prominent in the world in providing specialized health care, a pioneer in innovation, and an advanced medical research and education center.
  • To achieve world-class service in the clinical, research, and educational fields.

Results from Magenta Medical's US Early Feasibility Study of the World's Smallest and Most Powerful Heart Pump to be Highlighted at TCT 2023

Retrieved on: 
Tuesday, October 10, 2023

KADIMA, Israel , Oct. 10, 2023 /PRNewswire/ --Results from Magenta Medical's Early Feasibility Study of the Elevate™ System, for the high-risk percutaneous coronary intervention (HR-PCI) indication, will be announced in an oral presentation at the Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the Cardiovascular Research Foundation in San Francisco. Elevate™ is the world's smallest and most powerful percutaneous Left Ventricular Assist Device (pLVAD).

Key Points: 
  • Elevate™ is the world's smallest and most powerful percutaneous Left Ventricular Assist Device (pLVAD).
  • Presentation title: Magenta Elevate™: First US Experience with High-Output, Low-French Size Percutaneous Mechanical Circulatory Support
    Session: TCT Innovation V: Innovation in Coronary Disease Diagnosis and Therapies/Featured Technological Trends: Percutaneous Mechanical Circulatory Support.
  • Magenta's US Early Feasibility Study was initiated to evaluate the safety and feasibility of the Elevate™ System in providing temporary mechanical circulatory support during HR-PCI procedures.
  • Fifteen patients were treated in the study at the Mount Sinai Hospital, St. Francis Hospital and Heart Center, and North Shore University Hospital.

Texas Children's Hospital Remains No. 1 Pediatric Hospital in the State of Texas for 15th Consecutive Year

Retrieved on: 
Wednesday, June 21, 2023

HOUSTON, June 21, 2023 /PRNewswire/ -- Texas Children's Hospital is proud and honored once again to be named a leader in pediatric health care by U.S. News & World Report, ranking No. 1 in Texas and No. 3 nationally in its 2023-2024 Best Children's Hospitals report.

Key Points: 
  • In December 2020, Texas Children's opened a first-of-its-kind dedicated floor designed by and for patients with adult congenital heart (ACH) disease.
  • Texas Children's ACH Program is accredited by the Adult Congenital Heart Association and is one of only four accredited programs in Texas.
  • In 2021, only 89 children's hospitals were ranked in at least one of the 10 pediatric specialties evaluated for this annual report.
  • Ten hospitals, including Texas Children's Hospital, ranked at the top of their class and were named to the 2022-2023 Honor Roll .

WakeMed Health & Hospitals Wins 2023 Premier Alliance Excellence Award

Retrieved on: 
Tuesday, June 20, 2023

Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, has named WakeMed Health & Hospitals , a nationally recognized 970-bed not-for-profit healthcare system founded and based in Raleigh, N.C., the winner of the 2023 Premier Alliance Excellence Award.

Key Points: 
  • Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, has named WakeMed Health & Hospitals , a nationally recognized 970-bed not-for-profit healthcare system founded and based in Raleigh, N.C., the winner of the 2023 Premier Alliance Excellence Award.
  • The Premier Alliance Excellence Award recognizes innovative healthcare providers that demonstrate an unparalleled commitment to healthcare transformation, using Premier as a key partner.
  • The health system has also joined Contigo Health to help increase access to high-quality care and control costs.
  • Previous Premier Alliance Excellence Award winners include Henry Ford Health (Detroit, MI), Atrium Health (Charlotte, NC), St. Luke’s University Health Network (Bethlehem, PA), McLaren Health Care (Detroit, MI), University Hospitals (Cleveland, OH), Baystate Health (Springfield, MA), Banner Health (Phoenix, AZ), Bon Secours Mercy Health (Cincinnati, OH), Inova (Falls Church, VA) and Texas Health Resources (Arlington, TX).

Repairon Announces Completion of Dose-Finding Part of BioVAT-HF Phase 1/2 Trial in Advanced Heart Failure

Retrieved on: 
Tuesday, April 4, 2023

The clinical trial is evaluating the safety and efficacy of iPSC1 -derived engineered human myocardium (EHM) as Biological Ventricular Assist Tissue (BioVAT) in Advanced Heart Failure (NCT04396899).

Key Points: 
  • The clinical trial is evaluating the safety and efficacy of iPSC1 -derived engineered human myocardium (EHM) as Biological Ventricular Assist Tissue (BioVAT) in Advanced Heart Failure (NCT04396899).
  • Strongly encouraged by the emerging data from the BioVAT-HF study, Repairon will continue the commercial development of the EHM technology with the aim to establish it as the therapeutic option of choice for patients with advanced heart failure."
  • "Advanced heart failure treatment requires new reparative therapies; with BioVAT-HF remuscularization of the failing heart is becoming a clinical possibility," said Professor Stefan Anker Charité Berlin.
  • The open-label, non-randomized, multi-center trial is investigating the hypothesis that cardiomyocyte implantation as BioVAT results in sustainable remuscularization and biological enhancement of myocardial performance in patients with advanced heart failure.

Penn Highlands Healthcare Introduces “Return to Work” Nursing Residency

Retrieved on: 
Monday, April 3, 2023

Do you know a family member or friend who took time off from their nursing career, but wants to go back to work?

Key Points: 
  • Do you know a family member or friend who took time off from their nursing career, but wants to go back to work?
  • Penn Highlands Healthcare is now offering a “Return to Work” Nursing Residency to help nurses return to the workforce.
  • The Return to Work Residency is an accelerated educational option that focuses on nurses who already have completed a nursing degree program.
  • Once a nurse completes the program, there are various job opportunities available at Penn Highlands hospitals and skilled nursing facilities including full- and part-time positions as well as casual schedules.

Bayer Announces First Patients Enrolled in Global Phase III Studies for Investigational Oral FXIa Inhibitor Asundexian

Retrieved on: 
Wednesday, February 8, 2023

“Additional research into the combination of FXI inhibition and antiplatelet agents is needed to explore potential treatment options for the future.”

Key Points: 
  • “Additional research into the combination of FXI inhibition and antiplatelet agents is needed to explore potential treatment options for the future.”
    “Through our OCEANIC clinical trial program, Bayer leverages decades of cardiovascular expertise to investigate a potential new class of antithrombotics and explore the potential of asundexian as an additional antithrombotic treatment option across multiple patient populations,” 1-2 said Maria Borentain, M.D., Vice President and Head of Thrombosis and Vascular Disease Clinical Development, Bayer.
  • Effect of factor XIa inhibition with asundexian on recurrent ischemic stroke according to baseline patterns of infarction on brain MRI: PACIFIC-Stroke.6
    Khatri P, Shoamanesh A, Mundl H, et al.
  • Effects of the oral factor XIa inhibitor asundexian on intracranial bleeding among patients with acute non-cardioembolic ischemic stroke: PACIFIC-Stroke randomized trial.
  • 7

Texas Children's Hospital Elevates National Ranking to Second Among Best Children's Hospitals by U.S. News & World Report

Retrieved on: 
Tuesday, June 14, 2022

HOUSTON, June 14, 2022 /PRNewswire/ -- Texas Children's Hospital is proud to consistently be recognized as a leader in pediatric care by U.S. News & World Report, placing second nationally in its new 2022-2023 Best Children's Hospitals rankings. The hospital rose from a No. 3 ranking on this annual report in 2021-2022.

Key Points: 
  • In December 2020, Texas Children's opened a first-of-its-kind dedicated facility designed by and for adults with congenital heart (ACH) disease.
  • Texas Children's ACH Program is accredited by the Adult Congenital Heart Association and is one of only four accredited programs in Texas.
  • U.S. News & World Report introduced the Best Children's Hospitals ranking in 2007 to help families of children with rare or life-threatening illnesses find the best medical care available.
  • Texas Children's Hospital is affiliated with Baylor College of Medicine.For more information, go to www.texaschildrens.org .

Four Decades of Saving Kids' Hearts: Stanford Children's Health Celebrates its 500th Pediatric Heart Transplant

Retrieved on: 
Monday, December 13, 2021

STANFORD, Calif., Dec. 13, 2021 /PRNewswire/ -- Stanford Children's Health , with Lucile Packard Children's Hospital Stanford at its center, is celebrating its 500th pediatric heart transplant.

Key Points: 
  • STANFORD, Calif., Dec. 13, 2021 /PRNewswire/ -- Stanford Children's Health , with Lucile Packard Children's Hospital Stanford at its center, is celebrating its 500th pediatric heart transplant.
  • This holiday season, 14-year-old Mackenzie Collins , the 500th Stanford Children's Health pediatric heart recipient, will be celebrating a healthy heart at home with her family.
  • It took a multidisciplinary team of pediatric heart surgeons , transplant cardiologists, nurses , pediatric anesthesiologists , surgical technicians, transport, and transplant specialists to achieve the successfulsix-hour open-heart surgery transplant.
  • 2020: Stanford Children's Health performed 24 heart transplants and implanted 18 ventricular assist devices , to extend patients' lives until they receive a donor heart.